182 related articles for article (PubMed ID: 23857189)
1. Expression and clinical role of small glutamine-rich tetratricopeptide repeat (TPR)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC.
Xue Q; Lv L; Wan C; Chen B; Li M; Ni T; Liu Y; Liu Y; Cong X; Zhou Y; Ni R; Mao G
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1539-49. PubMed ID: 23857189
[TBL] [Abstract][Full Text] [Related]
2. Polycomb group oncogene RING1 is over-expressed in non-small cell lung cancer.
Zhou Y; Wan C; Liu Y; Lv L; Chen B; Ni R; Huang Y; Li Y; Zheng X; Yang D; Mao G; Xue Q
Pathol Oncol Res; 2014 Jul; 20(3):549-56. PubMed ID: 24414991
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.
Lin G; Sun L; Wang R; Guo Y; Xie C
J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.
Zhu T; Ji Z; Xu C; Peng Z; Gu L; Zhang R; Liu Y
J Mol Histol; 2014 Dec; 45(6):665-77. PubMed ID: 25027991
[TBL] [Abstract][Full Text] [Related]
7. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
9. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.
Li H; Zhou RJ; Zhang GQ; Xu JP
Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668
[TBL] [Abstract][Full Text] [Related]
11. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
[TBL] [Abstract][Full Text] [Related]
12. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.
Liao Y; Ni Y; He R; Liu W; Du J
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1523-8. PubMed ID: 23835897
[TBL] [Abstract][Full Text] [Related]
14. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
[TBL] [Abstract][Full Text] [Related]
15. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
16. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
Zhang Y; Ma M; Han B
Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
[TBL] [Abstract][Full Text] [Related]
17. Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.
Liu X; Liu B; Cui Y; Wang F; Sun H; Lv F
Tumour Biol; 2014 Nov; 35(11):11677-83. PubMed ID: 25139095
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of phosphorylated mTOR/RPS6KB1 in non- small cell lung cancer.
Zhang Y; Ni HJ; Cheng DY
Asian Pac J Cancer Prev; 2013; 14(6):3725-8. PubMed ID: 23886172
[TBL] [Abstract][Full Text] [Related]
19. Pathobiological implications of MUC4 in non-small-cell lung cancer.
Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
[TBL] [Abstract][Full Text] [Related]
20. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]